Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: Comparison of extended hysterectomy and extrafascial hysterectomy

International Journal of Gynecological Cancer

Volumn 20, Issue 2, 2010, Pages 268-275

  Motton, Sté Phanie ^a   Houvenaeghel, Gilles ^b   Delannes, Martine ^c   Querleu, Denis ^c   Soulé Tholy, Marc ^a   Hoff, Jean ^a   Guevaque, Pierre Lè ^a  

^a CHU RANGUEIL   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Cervical cancer; Chemoradiotherapy; Extrafascial hysterectomy; Radical hysterectomy; Surgery

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER; ADJUVANT THERAPY; CARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; FRANCE; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PELVIS; POSTOPERATIVE COMPLICATION; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; HYSTERECTOMY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PELVIS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 77951891308     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181c9e385     Document Type: Article

References (18)

1. Mohar A, Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest. 2000;18:584-590.
2. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137-1143.
4. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
5. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
6. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
7. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
8. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357.
9. Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67:2776-2785.
10. Mauriac L. Fédération nationale des centres de lutte contre le cancer. Standard/Options et Recommandations. Cancer invasif du col utérin. Stades non métastatiques. Paris, France: Arnette Blackwell; 1996.
11. Houvenaeghel G, Lelievre L, Gonzague-Casabianca L, et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol. 2006;100:338-343.
12. Classe JM, Rauch P, Rodier JF, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006;102:523-529.
13. Resbeut M, Cowen D, Viens P, et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol. 1994;54:68-75. (Pubitemid 24239411)
14. Houvenaeghel G, Lelievre L, Buttarelli M, et al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol. 2007;33:498-503.
15. Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003;89:343-353.
16. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3-12.
17. Houvenaeghel G, Buttarelli M, de Troyer J, et al. Surgical resection after chemotherapy for advanced cervical carcinoma. Cancer Radiother. 2006;10:471-476.
18. Motton S, Leguevaque P, Dellaparent T. Role of 2-[18F]-fluoro-2-deoxy-D- glucose (FDG) positron emission tomography (PET) scan in the evaluation of cervical tumoral and lymph node residual disease after concurrent chemoradiation therapy in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2009;19:8-12.